October 21, 2019. The Marble Center Distinguished Seminar series will feature Dr. Samir MitragotriHiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering at Harvard University. The title of his talk is Bioinspired and Biomimetic Strategies for Targeting Tumors.

Prof. Mitragotri's research has provided new insights into biological barriers of skin and gastrointestinal tract, among others. His research has also led to new methods of transdermal, oral, and targeted drug delivery systems. He is an author of over 280 publications and is a Thomson Reuters Highly Cited Researcher. Prof Mitragotri is highly active in translating his inventions to clinical and commercial products. He is an inventor on over 170 patent/patent applications. His inventions have led to several products that have been commercialized or are in advanced clinical development. He is an elected member of the National Academy of Engineering, National Academy of Medicine and National Academy of Inventors. He is a foreign member of Indian National Academy of Engineering. He is also an elected fellow of AAAS, CRS, BMES, AIMBE, and AAPS. He received BS in Chemical Engineering from the Institute of Chemical Technology, India and PhD in Chemical Engineering from the Massachusetts Institute of Technology. He is the Editor-in-Chief of AIChE’s and SBE’s journal Bioengineering and Translational Medicine.


Join fellow graduate students and postdocs from across the nano and biomedical research spectra of MIT to brainstorm and build innovative solutions for problems in healthcare and nanotechnology! You'll learn a hands-on process for understanding problems in healthcare and working on breakthrough solutions. You will also find a great opportunity to meet new research or venture collaborators at MIT with shared interests. 

General workshop structure:

  • Intro to the process of hacking
  • Problem definition
  • Solution development
  • Final pitch to judges



Monday July 22, 2019 


Location: MIT.nano Teaching Space (basement level)


June 17, 2019. The Marble Center Distinguished Seminar series will feature Dr. Kostas KostarelosChair of Nanomedicine and Professor of Biology, Medicine and Health & the National Graphene Institute, University of Manchester.  
The title of his talk is Transformation of Graphene Nanomaterials for Medicine.

Kostas obtained his Diploma in Chemical Engineering and PhD from the Department of Chemical Engineering at Imperial College London, studying the steric stabilization of liposomes using block copolymer molecules. He carried out his postdoctoral training in various medical institutions in the United States and has worked closely with D. Papahadjopoulos (UCSF, USA), G. Sgouros (Memorial Sloan-Kettering, NY, USA) and R.G. Crystal (Weill Medical College of Cornell University, NY, USA). He was Assistant Professor of Genetic Medicine & Chemical Engineering in Medicine at Cornell University Weill Medical College when he relocated to the UK as the Deputy Director of Imperial College Genetic Therapies Centre in 2002. In 2003 he joined the Centre for Drug Delivery Research at the UCL School of Pharmacy as the Deputy Head of the Centre. He was promoted to the Personal Chair of Nanomedicine and Head of the Centre in 2007. The entire Nanomedicine Lab was embedded within the Faculty of Medical and Human Sciences and the National Graphene Institute at the University of Manchester in 2013. Kostas is currently Professor of Nanomedicine at the University of Manchester and Visiting Professor at UCL Faculty of Life Sciences. He has been invited Fellow of the Royal Society of Chemistry (FRSC), Fellow of the Royal Society of Medicine (FRSM), and Fellow of the Royal Society of Arts (FRSA) all in the United Kingdom. In 2010 he was awarded the Japanese Society for the Promotion of Science (JSPS) Professorial Fellowship with the National Institute of Advanced Industrial Science and Technology (AIST) in Tsukuba, Japan. He has been included in the Highly Cited Researcher 2018 list ( in the Cross-Field category. He is the Founding and Senior Editor of the journal Nanomedicine and sits on the Editorial Board of: ACS Nano, Bioconjugate Chemistry (ACS), 2D Materials (IOP), 2D Materials & Applications (NPJ), Archives in Toxicology (Springer), Nanoscale Horizons (RSC), Journal of Visualized Experiments (JoVE), Applied Materials Today (Elsevier), The Journal of Liposome Research (Taylor & Francis).

November 19, 2018. The Marble Center Distinguished Seminar series will feature Dr. Timothy Rebbeck,  the Vincent L. Gregory, Jr. Professor of Cancer Prevention Professor at the Dana Farber Cancer Institute and the Harvard T.H. Chan School of Public Health. Dr. Rebbeck leads an early detection effort at the T.H. Chan School of Public Health, and is looking to engage the technology community around these challenges in the context of cancer. His research also focuses on the prevention of cancer, with an emphasis on cancers with a genetic etiology and those that are associated with disparities in incidence or mortality by race.


October 22, 2018. This month's Marble Center will feature an overview of PanCancer Atlas presented by Dr. Robert Kruger from Cell Press. The PanCancer Atlas is a detailed genomic analysis on a data set of molecular and clinical information from over 10,000 tumors representing 33 types of cancer. The entire collection of papers comprising the PanCancer Atlas are available through a portal on


Dr. Kruger is Deputy Editor at Cell.  He joined Cell in 2005 with a research background in biochemistry and cell and developmental biology. He holds degrees in Biology from the University of Sussex (MPhil) and in Neuroscience (Ph.D.) from the University of Michigan, where he trained in the laboratories of Kun-liang Guan and Jack Dixon.


May 21, 2018. The Marble Center kicks off this year's Distinguished Seminar Series with a lecture by Dr. William Sellers entitled "From Cancer Dependence to Cancer Therapeutics." Dr. Sellers is a Core Institute Member at the Broad Institute and a Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School where he runs a research group focused on translating genomic discoveries into new therapeutics. Previously, Dr. Sellers directed cancer drug discovery and early cancer clinical development at the Novartis Institutes for BioMedical Research overseeing scientists, clinicians and clinical staff on sites in Cambridge, East Hanover, Basel and Shanghai from 2005-2016. Since joining Novartis in 2005 the oncology research group brought more than 30 small molecule, biologic and cell-based cancer therapeutics into first-in-man trials including therapeutics targeting the PI3K, CDK4, IDH, ABL, SMO, HER3, ALK, Wnt, PIM and Ras pathways among others. During his tenure, he conceptualized and directed the collaboration with the Broad Institute on the Cancer Cell Line Encyclopedia, the development of the Novartis Primary Derived Xenograft Encyclopedia and large-scale efforts to functionally characterize the cancer genome. Along with Dr. Carl June, he co-chaired the CART collaboration with the University of Pennsylvania that brought CTL019 to a recent FDA approval.

Dr. Sellers previously was an Associate Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School and an  
Associate Member of the Broad Institute. Together with Matthew Meyerson, he initiated and developed large-scale efforts to resequence genes in diverse cancer types. In addition they pioneered the use of high-density SNP arrays for defining LOH and copy number alterations across cancer including the development of the widely used GISTIC algorithm. These projects led to discovery of EGFR mutations in lung adenocarcinoma and the discovery of the oncogenic role of the MITF gene in melanoma. In addition, his work advanced the understanding of the molecular mechanisms of growth regulation of the PTEN tumor suppressor gene. Dr. Sellers was a member of the National Cancer Advisory Board. Dr. Sellers received his B.S. from Georgetown University in 1982 and M.D. from the University of Massachusetts Medical School in 1986. He completed residency training in Internal Medicine at the University of California San Francisco in 1989 and trained in Medical Oncology at the Dana-Farber Cancer Institute.



December 18, 2017. This month's Marble Center seminar will feature a hot topic on the emerging trend of preprint in life sciences. The discussion will be moderated by a Dr. Rosalind Mott, Scientific Editor at Cell Press. More background on the topic can be found in this recent publication in the journal Science

Dr. Rosalind Mott received her Ph.D. from The University of Virginia in biomedical engineering, investigating integrated cellular responses to applied force. She then moved to the University of Pennsylvania to determine the impact of traumatic brain injury (TBI) on mRNA translational mechanisms. This work led her to research neuronal network remodeling and develop therapeutic strategies to target aberrant protein translation and mitochondrial dysfunction to facilitate network recovery after mild TBI. She joined the Cell Metabolism editorial team in December 2015 and has a strong interest in transforming traditional modes of scientific communication.


October 30, 2017. This month's Marble Center seminar will feature a research update by Dr. Ana Jaklenec from the Langer lab on "Drug Delivery Technology for Pulsatile Release of Biologics," as well as an industry panel on "Emerging Technologies:"

  • Dr. Andrew Warren is a Founding Scientist & Product Development Lead at Glympse Bio, a seed-stage startup developing a diagnostic drug platform originally invented in Professor Sangeeta Bhatia’s lab at MIT.
  • Dr. Pengpeng Cao is a Senior Scientist at Torque Therapeutics where she develops new classes of cell-based immunotherapeutics to boost the potential of immunotherapy for cancer treatment.
  • Dr. Vyas Ramanan is an Associate at Third Rock Ventures where he focuses on new company formation and due diligence.
  • Dr. Fiona Sharp is an Investigator in the exploratory immune-oncology group at Novartis. Her research focuses on enhancing our understanding of immune checkpoint pathways for the development of anti-tumor immune responses.
  • Dr. Jenna Sullivan is a Senior Imaging Scientist at inviCRO, LLC. where designs and directs preclinical and translational imaging studies to support drug discovery and development.
  • Dr. Carl Schoellhammer is the co-founder and CEO of Suono Bio, a preclinical-stage company focused on the ultra-rapid delivery of novel therapeutics to the gastrointestinal tract.
  • Dr. Michael Look is a senior scientist at Pfizer’s Inflammation and Immunology Research Unit, where he develops novel targets related to the treatment of autoimmune diseases and inflammatory disorders.


October 9, 2017. The Marble Center announced today the first class of Convergence Scholars. The Convergence Scholars Program aims at cultivating in postdoctoral trainees an integrative vision of science and technology. The program will provide postdoctoral trainees with opportunities to further their experiences and skills beyond the research laboratory space. Click here to access the press release.


May 30, 2017. Dr. Polina Anikeeva, the MIT Class of 1942 Associate Professor of Materials Science and Engineering, will present her research on "Probing Neural Function with Electronic, Optical, and Magnetic Materials" at the next Marble Center Seminar on Tuesday May 30, 2017 (5pm). More information about Dr. Anikeeva's research group can be found here.

April 20, 2017. As part of the Koch Institute's outreach effort at the 2017 Cambridge Science Festival, Marble Center researchers designed a pop-up mini golf course on cancer nanomedicine featuring concepts from the fields of targeted drug delivery, nanoscience, tumor biology. Kids and adults took a swing at various biomedical challenges in this course (as well as several others organized by Koch Institutes researchers) to learn more about the ins and outs of cancer.


November 15, 2016. Dr. Ji-Ho (Joe) Park will be presenting his research on "Harnessing Exocytosis of Nanoparticles to Improve Cancer Nanomedicine” on Tuesday November 15, 2016. Dr. Park is an Associate Professor of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIST, South Korea). Lunch will be served at 12:30pm and the talk will start at 1pm. Click here for more information.


October 9, 2016. In honor of the first annual celebration of National Nanotechnology Day, the Koch Institute for Integrative Cancer Research at MIT presents an interactive peek into how researchers across the MIT campus are using nanomaterials to explore and improve the world. Open the collage below for a big picture view of the tiny technologies exhibited in the Koch Institute Public Galleries. Each square links to one image in our online galleries; click to learn more!